KY
Kyntra Bio, Inc.
KYNB · NASDAQ
$7.98 +2.37% (+$0.18)
1M +13.72%
Market Cap $32.5M
P/E Ratio 0.18x
Div. Yield -
ROE -
Bulios Fair Price
$11.2
40.4% upside
Trenutna cena
$7.98
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica KYNB trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
72 /100
Cheap P/S 7.05x
P/E 0.18x
P/FFO N/A
Growth
0 /100
Declining Rev. growth 64.23%
Book val. growth N/A
EPS growth N/A
Profitability
25 /100
Weak Op. margin 1,101.02%
Gross margin 18.15%
FCF margin 824.39%
Quality
22 /100
Poor Asset turnover 0.05x
ROIC 78.16%
ROA 181.24%
Debt
43 /100
Moderate Int. coverage -10.14x
Current ratio 2.69x
Debt/Assets N/A
Stability
39 /100
Moderate EPS volatility 5,488.80%
Beta 1.06x
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o KYNB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Thane Wettig
Employees
34
Headquarters
San Francisco
Prihajajoči dogodki
09 NOV.
Earnings
Upcoming earnings report